Observational studyBlood2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Paul J Martin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled ittrialcites it